how exactly does tirzepatide work vs. Semaglutide: Which Weight Loss Medication Is Right for You? Tirzepatide: How Does It Work

accordingly, the group has submitted several abstracts to the 2026 ASCO Annual Meeting covering GLP-1 receptor agonist use in prevention across multiple malignancies, including pancreatic cancer and leukemias, one of which was accepted for an oral podium presentation

Who is a Good Candidate for Medical Weight Loss

Risk scores improved for diabetic members taking GLP-1s

Increased plasma DPP4 activity is an independent predictor of the onset of metabolic syndrome in Chinese over 4 years: result from the China national diabetes and metabolic disorders study

Not evaluated or approved by the FDA

Patient consent for publication Not applicable